BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37243749)

  • 21. Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
    Dar H; Johansson A; Nordenskjöld A; Iftimi A; Yau C; Perez-Tenorio G; Benz C; Nordenskjöld B; Stål O; Esserman LJ; Fornander T; Lindström LS
    JAMA Netw Open; 2021 Jun; 4(6):e2114904. PubMed ID: 34190995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.
    Farhat GN; Cummings SR; Chlebowski RT; Parimi N; Cauley JA; Rohan TE; Huang AJ; Vitolins M; Hubbell FA; Manson JE; Cochrane BB; Lane DS; Lee JS
    J Natl Cancer Inst; 2011 Apr; 103(7):562-70. PubMed ID: 21330633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
    Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
    JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal Female Hormone Use and Estrogen Receptor-Positive and -Negative Breast Cancer in African American Women.
    Rosenberg L; Bethea TN; Viscidi E; Hong CC; Troester MA; Bandera EV; Haiman CA; Kolonel LN; Olshan AF; Ambrosone CB; Palmer JR
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26613937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
    Parise CA; Bauer KR; Brown MM; Caggiano V
    Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis.
    Holm J; Li J; Darabi H; Eklund M; Eriksson M; Humphreys K; Hall P; Czene K
    J Clin Oncol; 2016 Jan; 34(3):251-8. PubMed ID: 26628467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women.
    Barber LE; Zirpoli GR; Cozier YC; Rosenberg L; Petrick JL; Bertrand KA; Palmer JR
    Breast Cancer Res; 2021 Nov; 23(1):108. PubMed ID: 34809694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary index scores and invasive breast cancer risk among women with a family history of breast cancer.
    Petimar J; Park YM; Smith-Warner SA; Fung TT; Sandler DP
    Am J Clin Nutr; 2019 May; 109(5):1393-1401. PubMed ID: 30968114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort.
    Shackshaft L; Van Hemelrijck M; Garmo H; Malmström H; Lambe M; Hammar N; Walldius G; Jungner I; Wulaningsih W
    Breast Cancer Res; 2017 Mar; 19(1):22. PubMed ID: 28264697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies.
    Kensler KH; Poole EM; Heng YJ; Collins LC; Glass B; Beck AH; Hazra A; Rosner BA; Eliassen AH; Hankinson SE; Winer EP; Brown M; Tamimi RM
    J Natl Cancer Inst; 2019 Jul; 111(7):700-708. PubMed ID: 30445651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.
    Phipps AI; Buist DS; Malone KE; Barlow WE; Porter PL; Kerlikowske K; Li CI
    Cancer Causes Control; 2011 Mar; 22(3):399-405. PubMed ID: 21184265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of breast cancer and family history of other cancers in first-degree relatives in Chinese women: a case control study.
    Zhou W; Ding Q; Pan H; Wu N; Liang M; Huang Y; Chen L; Zha X; Liu X; Wang S
    BMC Cancer; 2014 Sep; 14():662. PubMed ID: 25212775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between China's Great famine and risk of breast cancer according to hormone receptor status: a hospital-based study.
    Alimujiang A; Mo M; Liu Y; Huang NS; Liu G; Xu W; Wu J; Shen ZZ; Shao Z; Colditz GA
    Breast Cancer Res Treat; 2016 Nov; 160(2):361-369. PubMed ID: 27696082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of Reproductive Factors on the Risk of Breast Cancer by ER/PR and HER2: A Multicenter Case-Control Study in Northern and Eastern China.
    Xie F; Liu L; Yang H; Liu M; Wang S; Guo J; Yu L; Zhou F; Wang F; Xiang Y; Yu Z; Wang S
    Oncologist; 2022 Feb; 27(1):e1-e8. PubMed ID: 35305101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women's Health Study.
    Gapstur SM; Potter JD; Drinkard C; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):313-8. PubMed ID: 7655324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol and risk of breast cancer in postmenopausal women: an analysis of etiological heterogeneity by multiple tumor characteristics.
    Falk RT; Maas P; Schairer C; Chatterjee N; Mabie JE; Cunningham C; Buys SS; Isaacs C; Ziegler RG
    Am J Epidemiol; 2014 Oct; 180(7):705-17. PubMed ID: 25150269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term consumption of non-fermented and fermented dairy products and risk of breast cancer by estrogen receptor status - Population-based prospective cohort study.
    Kaluza J; Komatsu S; Lauriola M; Harris HR; Bergkvist L; Michaëlsson K; Wolk A
    Clin Nutr; 2021 Apr; 40(4):1966-1973. PubMed ID: 33004231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in estrogen receptor subtype according to family history of breast cancer among Hispanic, but not non-Hispanic White women.
    Hines LM; Risendal B; Slattery ML; Baumgartner KB; Giuliano AR; Byers T
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2700-6. PubMed ID: 18843012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between common risk factors and molecular subtypes in breast cancer patients.
    Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
    Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.